29.01.2013 • News • Oxea • chemicals • chemical industry

Oxea Announces Sales Control on Intermediates in the Americas

Effective immediately Oxea will implement a 100% sales control in North and South America

The following Intermediates line products effective until further notice.

n-Propanol

n-Butanol

n-Propyl Acetate

n-Butyl Acetate

The sales control will be based on the average monthly consumption over the last 6 months or as allowed by contract.

Company

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Expert Insights

Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.